Showing results (181-190 of 684,479) with videos related to
Sort By:
Pageof 68,448
Trials|June 14, 2013
PARot--assessing platelet-rich plasma plus arthroscopic subacromial decompression in the treatment of rotator cuff tendinopathy: study protocol for a randomized controlled trialAndrew Carr, Cushla Cooper, Richard Murphy, et al.Journal of Vascular and Interventional Radiology : JVIR|April 16, 1998
Long-term follow-up after TIPS: use of Doppler velocity criteria for detecting elevation of the portosystemic gradientT P Murphy, R P Beecham, H M Kim, et al.Clinical Nutrition (Edinburgh, Scotland)|July 28, 2020
GripBMI - A fast and simple sarcopenia screening tool in post acute inpatient rehabilitationIrina Churilov, Leonid Churilov, Kim Brock, et al.The Journal of Biological Chemistry|August 22, 2001
A membrane-proximal basic domain and cysteine cluster in the C-terminal tail of CCR5 constitute a bipartite motif critical for cell surface expressionS Venkatesan, A Petrovic, M Locati, et al.Neurosurgical Focus|February 9, 2006
Image-guided radiosurgery in the treatment of spinal metastasesM J Murphy, S Chang, I Gibbs, et al.Journal of Manipulative and Physiological Therapeutics|June 10, 2006
Interexaminer reliability of the hip extension test for suspected impaired motor control of the lumbar spineDonald R Murphy, David Byfield, Peter McCarthy, et al.Veterinary Dermatology|November 25, 2025
Efficacy of Der f 2/Zen 1-LAMP1 Plasmid-Based Vaccine Immunotherapy in Dogs With Atopic Dermatitis: A Proof-of-Concept StudyPetra Bizikova, Chigusa Matsumoto, Shoji Ogino, et al.Pain|February 15, 2011
Safety and efficacy of pregabalin in patients with central post-stroke painJong S Kim, Guy Bashford, Kevin T Murphy, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 5, 2016
Cognitive-behavioral changes in amyotrophic lateral sclerosis: Screening prevalence and impact on patients and caregiversMeredith Bock, Y-Nhy Duong, Anthony Kim, et al.Annals of the Rheumatic Diseases|November 27, 2012
Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspectiveFabien B Vincent, Eric F Morand, Kim Murphy, et al.Pageof 68,448